Article Text
Abstract
The Inforare project aims to set up a system for the sharing of clinical and familial data, in order to study how genes are related to the severity of sickle cell disease. While the computerisation of clinical records represents a valuable research goal, an ethical framework is necessary to guarantee patients' protection and their rights in this developing field. Issues relating to patient information during the Inforare study were analysed by the steering committee. Several major concerns were discussed by the committee and formalised in the patients' information letter: educating patients to aid the recruitment of family members, rules of confidentiality and the disclosure of aggregate, individual and unexpected research results. This paper presents the main issues addressed.
- Applied and professional ethics
- biomedical research
- confidentiality/privacy
- database
- ethics
- general
- genetic
- sickle cell
Statistics from Altmetric.com
Footnotes
Funding Other funders: ANR, 212 rue de Bercy, 75012 Paris, France.
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.
Read the full text or download the PDF:
Other content recommended for you
- Would you terminate a pregnancy affected by sickle cell disease? Analysis of views of patients in Cameroon
- High body mass index in children with sickle cell disease: a retrospective single-centre audit
- ANCILLARY STUDIES IN CLINICAL TRIALS (R01): RFA-HL-12-012
- Sickle cell disease: at the crossroads of pulmonary hypertension and diastolic heart failure
- Ethical issues in predictive genetic testing: a public health perspective
- 2021 Western Medical Research Conference
- Grants and Contracts
- Sickle Cell Disease Genomics of Africa (SickleGenAfrica) Network: ethical framework and initial qualitative findings from community engagement in Ghana, Nigeria and Tanzania
- Midwest Clinical and Translational Research Meeting of CSCTR and MWAFMR
- Genetic causes of dilated cardiomyopathy